Supply Chain

Steady progress is occurring in the global effort to track pharmaceutical distribution, even as new technical and business opportunities appear

More warehouse capacity, plus a growing investment in robotics

Passive containers maintain a -20°C temperature spec

TransCelerate opens up its network to qualified researchers; Oracle has a new platform

SensiWatch Platform includes analytics and APIs for integrating supply-chain information

Also: more innovative cold-chain actions during the Covid-19 pandemic

1.3-million sq. ft to be added in the US and Europe

Guidance for companies starting out on the commercialization path

Guidance for companies starting out on the commercialization path

Chain of identity, chain of custody are high priorities for autologous therapies

Service can be multimodal and multi-provider, and is not device-dependent

California researchers needed to find a way to collaborate with their counterparts in Hong Kong

Trump administration goal: ‘substantial quantities of a safe and effective vaccine available for Americans by January 2021’

More packaging vendors are offering ‘curbside recyclable’ containers

Milken Institute survey finds nearly 300 therapies and vaccines

Strains are showing in drug supplies consumed in treating infected patients

DuPont/Cold Chain Technologies in thermal blankets; va-Q-tec in shipment tracking; big bucks for SkyCell

UPS and CVS Pharmacy collaborate for direct-to-patient delivery; but check out Matternet, UPS’ drone partner

Cellular and genetic therapies (CGTs) are a minor part of commercial business, but a growing part of research activity

Kit Check data show value of track-and-trace technology, especially during the Covid-19 pandemic

Service providers are resetting their business practices to cope with the pandemic

Now a Danaher Corp. asset, the former GE Healthcare Life Sciences business has been reshuffled

As of March 26, 71 treatments and 47 vaccines are in development

Passenger-based carriers are repurposing their flights

Healthcare Ready pools industry efforts

DEA-registered practitioners can prescribe without an in-person interview

Guidance enables these workers to continue reporting to work

But: the growth number of companies is exceeding the growth of trials

The big question is how well will the system respond to spikes in demand, and lack of product